Loading clinical trials...
Loading clinical trials...
The study aims to examine the combined effects of delta-9-tetrahydrocannabinol (∆-9-THC or THC) and iomazenil on thinking, perception, mood, memory, attention, and electrical activity of the brain (EE...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Yale University
NCT06894212 · Schizophrenia
NCT05989646 · Urinary Incontinence, Daytime Wetting, and more
NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more
NCT07466875 · Nicotine Dependence, Nicotine Withdrawal, and more
NCT06003036 · Schizophrenia, Schizoaffective Disorder
VA Connecticut Healthcare System
West Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions